Literature DB >> 27577248

[Iron deficiency, Fatigue and Restless-Legs-Syndrome].

Bettina Wurzinger1, Peter König2.   

Abstract

Iron deficiency without anaemia is a widespread health problem that often remains undetected. In this context, neurological and psychopathological problems like fatigue and poor concentration are a major issue, but also in Restless-Legs-Syndrome (RLS) iron deficiency is a key element.The exact pathogenesis is often unknown, however, it is known that iron is involved in several very important metabolic processes in the human body. In particular when it comes to fatigue and RLS, it's assumed that reduced activity of tyrosine hydroxylase - a central iron-dependent element of dopamine synthesis - can lead to deficiencies.As part of the therapy, oral iron supplementation is considered to be treatment of choice since it's most cost-effective and well tolerated. Intravenous iron treatment is indicated if primary attempts were not sufficient or not tolerated. To successfully replenish iron storages, about 500-1000 mg are needed. Doses of 200 mg can be administered (iron sucrose) or 1-2 single doses as for ferric carboxymaltose. A check of ferritin-levels not earlier than 8 weeks after last administration is recommended.

Entities:  

Keywords:  Fatigue; Iron deficiency; Restless-Legs-Syndrome

Mesh:

Substances:

Year:  2016        PMID: 27577248     DOI: 10.1007/s10354-016-0497-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  29 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

2.  Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women.

Authors:  Thomas Brownlie; Virginia Utermohlen; Pamela S Hinton; Christina Giordano; Jere D Haas
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

Review 3.  Iron deficiency in Europe.

Authors:  S Hercberg; P Preziosi; P Galan
Journal:  Public Health Nutr       Date:  2001-04       Impact factor: 4.022

4.  Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome.

Authors:  P J Cathébras; J M Robbins; L J Kirmayer; B C Hayton
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

5.  The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia.

Authors:  Richard P Allen; Sarah Auerbach; Huzefa Bahrain; Michael Auerbach; Christopher J Earley
Journal:  Am J Hematol       Date:  2013-03-12       Impact factor: 10.047

Review 6.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Iron status and restless legs syndrome in the elderly.

Authors:  S T O'Keeffe; K Gavin; J N Lavan
Journal:  Age Ageing       Date:  1994-05       Impact factor: 10.668

8.  Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants.

Authors:  P Galan; H C Yoon; P Preziosi; F Viteri; P Valeix; B Fieux; S Briançon; D Malvy; A M Roussel; A Favier; S Hercberg
Journal:  Eur J Clin Nutr       Date:  1998-06       Impact factor: 4.016

9.  Iron and the restless legs syndrome.

Authors:  E R Sun; C A Chen; G Ho; C J Earley; R P Allen
Journal:  Sleep       Date:  1998-06-15       Impact factor: 5.849

10.  Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study.

Authors:  Bernard Favrat; Katharina Balck; Christian Breymann; Michael Hedenus; Thomas Keller; Anna Mezzacasa; Christoph Gasche
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

View more
  2 in total

Review 1.  [Iron deficiency : Recognition and treatment].

Authors:  S von Haehling; H Ottenjann; S D Anker
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

2.  Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.

Authors:  T Arendt; M Morawski; I Friedrich; K Reimann; S Jankuhn; E Kirilina; J Stieler; M Sonntag; J Meijer; N Weiskopf; T Reinert
Journal:  Acta Neuropathol Commun       Date:  2021-03-22       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.